What question did this study set out to answer?

To review the distinct molecular mechanisms, histopathological characteristics, and clinical outcomes that differentiate the suppressor and mutator pathways in sporadic colorectal carcinogenesis.

January 1, 2010World Journal of Gastrointestinal OncologyOpen Access

Differential colorectal carcinogenesis: Molecular basis and clinical relevance

View Full Paper

Ask AI

Bookmark

Authors

AMAlberto MoránUniversidad Complutense de Madrid

Discussion

Member takes

Implication

Review reveals distinct molecular profiles and superior prognosis for mutator versus suppressor colorectal cancer, highlighting the clinical relevance of differential carcinogenic pathways.

Key Points

To review the distinct molecular mechanisms, histopathological characteristics, and clinical outcomes that differentiate the suppressor and mutator pathways in sporadic colorectal carcinogenesis.
Reviewed molecular and genetic evidence distinguishing the chromosomal instability (suppressor) pathway from the DNA mismatch repair (mutator) pathway in sporadic colorectal cancer.
Assessed gene alterations, including K-ras, APC, DCC, p53, hMLH1, and hMSH2, alongside histopathological and prognostic variations between tumor subtypes.
The traditional suppressor pathway exhibits chromosomal instability driven by mutations in classical oncogenes and tumor suppressors (K-ras, APC, DCC, p53) and Wnt signaling alterations.
The mutator pathway accounts for approximately 15% of sporadic colorectal cancer cases and arises from DNA mismatch repair defects (predominantly hMLH1 or hMSH2) causing microsatellite mutations.
Tumors originating via the mutator pathway demonstrate markedly better clinical outcomes and survival compared to tumors arising via the suppressor pathway.

Cite This Study

Alberto Morán (2010) studied this question.

synapsesocial.com/papers/6aa92009aa112b81ac0c01c3 https://doi.org/10.4251/wjgo.v2.i3.151

View Full Paper

Ask AI

Bookmark

Implication

Review reveals distinct molecular profiles and superior prognosis for mutator versus suppressor colorectal cancer, highlighting the clinical relevance of differential carcinogenic pathways.

Differential colorectal carcinogenesis: Molecular basis and clinical relevance

Discussion

Member takes

Implication

Key Points

Cite This Study

Differential colorectal carcinogenesis: Molecular basis and clinical relevance

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider